VIP regimen
WikiDoc Resources for VIP regimen |
Articles |
---|
Most recent articles on VIP regimen Most cited articles on VIP regimen |
Media |
Powerpoint slides on VIP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on VIP regimen at Clinical Trials.gov Clinical Trials on VIP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on VIP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on VIP regimen Discussion groups on VIP regimen Patient Handouts on VIP regimen Directions to Hospitals Treating VIP regimen Risk calculators and risk factors for VIP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for VIP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Etoposide-Ifosfamide-Cisplatin Regimen; VePesid-Ifosfamide-Platinol Regimen; VIP; VIP Regimen; VP16-Ifosfamide-Platinol Regimen
Overview
VIP regimen refers to a regimen consisting of etoposide (vepesid), ifosfamide and cisplatin (platinol) used for the treatment of advanced-stage germ cell gonadal cancers.
Regimen
VVePesid (etoposide)
IIfosfamide
PPlatinol (cisplatin)